IPH4502 Phase 1 Clinical Trial for Solid Tumors Expressing Nectin-4
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxModified Virus Shows Promise in Shrinking Tumors and Halting Cancer Growth
/0 Comments/in Not PCa related/by MaxGoogle’s AI-Driven Breakthrough: The Future of Drug Discovery
/0 Comments/in Artificial Intelligence/by MaxWe can’t always win: LAVA-1207 Development Discontinued, Not Related to Safety Issues
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxNewsletter 3/2025
/0 Comments/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi, fellow fighters! Ok, this week I had to take some time off for my PET scan and checkup, so I haven’t gathered as much information as usual to share with you. Nonetheless, what I found is still very interesting and promising! […]
PARP Inhibitors in Prostate Cancer: Navigating the Complexities of DNA Repair
/0 Comments/in Review/by MaxUpdate on CLS-1025: Precision T Cell Engager Phase 1 Study Expected in Early 2025
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxUMass Scientists Develop Novel Bacteria-Based Cancer Therapy
/0 Comments/in Oncolytic, Preclinical Research/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
abiraterone acetate ADC ADT AI ai in healthcare alphafold antibody-drug conjugate apalutamide artificial intelligence ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy cancer treatment cancer vaccine clinical trial clinical trials crispr darolutamide drug repurposing drug resistance enzalutamide hormone therapy immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA nanotechnology neuroendocrine prostate cancer oncology oncolytic virus personalized medicine prostate cancer PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy targeted drug delivery theranostics
Latest Posts
- Predictive Oncology’s Breakthrough in Drug Repurposing Offers Hope for Patients April 16, 2025
- Phase 1 Soon Recruiting: MK-2400 (Ifinatamab Deruxtecan) for Metastatic Prostate Cancer April 15, 2025
- Newsletter 15/2025 April 13, 2025
- Phase 1 Trial: The COSMYC Trial, ZEN-3694 Combination With BAT April 11, 2025